• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (57)
    • Characteristics of Biostatistics, Epidemiology, and Research Design Programs in Institutions With Clinical and Translational Science Awards.
    • Use of a coronary sinus lead and biventricular ICD to correct a sensing abnormality in a patient with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    • Accommodative esotropia: the state of the art.
    • Are low-volume ERCPists a problem in the United States? A plea to examine and improve ERCP practice-NOW.
    • Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth.
    • See All 57 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth.

Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth. Cancer Res. 2007 Oct 15; 67(20):9980-5.

View in: PubMed

subject areas
  • Angiogenesis Inhibitors
  • Animals
  • Antigens, Bacterial
  • Bacterial Toxins
  • Carcinoma, Lewis Lung
  • Cell Growth Processes
  • Cornea
  • Corneal Neovascularization
  • Endothelial Cells
  • Fibroblast Growth Factor 2
  • Humans
  • Membrane Proteins
  • Mice
  • Mice, Inbred C57BL
  • Microfilament Proteins
  • Mutation
  • Neoplasm Proteins
  • Neovascularization, Pathologic
  • Neovascularization, Physiologic
  • Receptors, Cell Surface
  • Receptors, Peptide
  • Vascular Endothelial Growth Factor A

authors with profiles
  • Kenneth A Christensen